CASC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Inventory divides by its Total Current Liabilities. Cascadian Therapeutics Inc's quick ratio for the quarter that ended in Sep. 2016 was 9.92.
Cascadian Therapeutics Inc has a quick ratio of 9.92. It generally indicates good short-term financial strength.
During the past 13 years, Cascadian Therapeutics Inc's highest Quick Ratio was 36.71. The lowest was 0.95. And the median was 11.75.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Cascadian Therapeutics Inc's Quick Ratio for the fiscal year that ended in Dec. 2015 is calculated as
|Quick Ratio (A: Dec. 2015 )||=||(Total Current Assets||-||Inventory)||/||Total Current Liabilities|
Cascadian Therapeutics Inc's Quick Ratio for the quarter that ended in Sep. 2016 is calculated as
|Quick Ratio (Q: Sep. 2016 )||=||(Total Current Assets||-||Inventory)||/||Total Current Liabilities|
The quick ratio is more conservative than the current ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Cascadian Therapeutics Inc Annual Data
Cascadian Therapeutics Inc Quarterly Data